Back to Rankings

ADCT

ADC TherapeuticsC
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ADCT vs peer average
59/100
ADCT vs. peer average (C vs. D)
Grade spread
A 1 · B 3 · C 1 · D 1 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

DMAC is the first available peer comparator.

Comparable small-cap clinical-stage biotech; similar event-driven volatility and sensitivity to binary trial/regulatory outcomes.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerDMACDiaMedica Therapeutics
ADCT
ADC Therapeutics
DMAC
DiaMedica Therapeutics
Grade
C
F
Momentum
8
88
Value
41
41
Sentiment
100
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive

Grade position vs DMAC

ADCT / DMAC
Grade Position
In line
ADCT vs. peer average (C vs. D)
59/100
Momentum
8
DMAC
Value
41
ADCT
Sentiment
100
ADCT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ADCT
1
DMAC
DMAC
F
20/100
+2
2
ETON
ETON
C
60/100
Even
3
IMRX
IMRX
B
80/100
-1
4
IMDX
Insight Molecular Diagnostics Inc Common
F
20/100
+2
5
LENZ
LENZ Therapeutics Inc Common
B
80/100
-1
DMAC is the first peer returned for this comparison set.